SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-174232
Filing Date
2020-06-19
Accepted
2020-06-19 17:19:03
Documents
7
Period of Report
2020-06-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d696347d8k.htm 8-K 22932
2 EX-10.1 d696347dex101.htm EX-10.1 27158
3 EX-10.2 d696347dex102.htm EX-10.2 31284
4 EX-10.3 d696347dex103.htm EX-10.3 67608
5 EX-10.4 d696347dex104.htm EX-10.4 3186
6 EX-10.5 d696347dex105.htm EX-10.5 76231
7 EX-10.6 d696347dex106.htm EX-10.6 74489
  Complete submission text file 0001193125-20-174232.txt   304259
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-49908 | Film No.: 20976552
SIC: 2834 Pharmaceutical Preparations